Loading GYRE charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading GYRE comparable companies…
| GYREGyre Therapeutics, Inc.(opens in a new tab) | $0.46B | $0.12B | +13.5% | 94.3% | −14.0% | 3.84× | — |
|---|---|---|---|---|---|---|---|
| SPRYARS Pharmaceuticals, Inc.(opens in a new tab) | $0.33B | $0.12B | +4.1% | 100.0% | −185.0% | 2.86× | — |
| LFCRLifecore Biomedical, Inc.(opens in a new tab) | $0.24B | — | — | — | — | — | — |
| ETONEton Pharmaceuticals, Inc.(opens in a new tab) | $1.71B | $0.11B | +81.5% | 57.9% | 15.4% | 16.19× | — |
| XNCRXencor Inc(opens in a new tab) | $2.26B | $0.10B | −28.6% | — | −205.8% | 21.56× | — |
| Medianpeers, excl. GYRE | $1.02B | $0.11B | +4.1% | 78.9% | −185.0% | 16.19× | — |